A single strain (8021) of Neisseria meningitidis, isolated from a child with disseminated meningococcal disease, was found to elaborate two serogroup-specific capsular polysaccharides -Y and W135. The original isolate as well as the progeny of ten single colony sub-isolates each agglutinated with both group Y and group W 135 serogrouping antisera. The capsular polysaccharide of strain 8021 contained the chemical constituents of both the W135 and Y capsular polysaccharides in a ratio of about 2.5: 1. The patient responded immunologically to both capsular polysaccharides with haemagglutinating antibodies. Analysis by double diffusion in agar revealed that the capsular polysaccharide of strain 8021 contained individual molecules of group W 135 and group Y capsular polysaccharides as well as a mosaic molecule containing both antigenic determinants.
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I N T R O D U C T I O N
Strains of Neisseria meningitidis are divided into serogroups on the basis of the chemical structure and immunological specificity of their capsular polysaccharides, which are mutually exclusive and believed to be under chromosomal genetic control, in keeping with those of strains of the Enterobacteriaceae (Orskov et al., 1977) . Several pairs, however, are chemically quite similar and cross-react serologically to varying degrees (Bhattacharjee et al., 1975 (Bhattacharjee et al., , 1976 Craven et al., 1978) . One such pair, groups Y and W135, produce co-polymers of alternating sialic acid and hexose, with the hexose being either glucose (group Y) or galactose (group W135) (Bhattacharjee et al., 1976) . When administered to mammals, including man, either polysaccharide may induce antibody to the other in some, but not all, individuals (Craven et al., 1978; B. L. Brandt & J. McL. Griffiss, unpublished results) . In the course of confirming the serogroup of strains isolated from patients with disseminated meningococcal disease, we encountered a single strain which elaborates both the group Y and group W135 capsular polysaccharides as well as a mosaic molecule containing both immunological determinants. Details of the characterization of this strain are presented below.
METHODS

Bacteriology.
Strain 8021 was isolated from a paediatric patient with meningococcal meningitis at Ft Lewis, Washington, U.S.A. (Griffiss & Brandt, 1979) . It was determined to be N . meningitidis by Gram-stained morphology, oxidase production and characteristic carbohydrate utilization.
Two lots of capsular polysaccharide were prepared from 16 h liquid cultures of single colonies of strain 8021. * Determined by quantitative gas-liquid chromatography with added internal standard.
i. Determined by gas-liquid chromatography.
as a vaccine for human use, by the method of Berman et al. (1970) . Monovalent group Y and group W135 capsular polysaccharide vaccines, prepared from standard seed strains (80Y and 22-W 135), and a bivalent vaccine containing both capsular polysaccharides combined in a 50: 50 ratio, by weight, were tested for comparison. All three vaccines were prepared by the method of Eerman et al. (1970) for human use and have been extensively tested in human volunteers.
Chemistry. Each lot of 802 1 polysaccharide was analysed qualitatively by gas-liquid chromatography (Pier et a/., 1978) . The polysaccharides were hydrolysed with 3 "/o methanolic HCI, re-N-acetylated with acetic anhydride and converted to the trimethylsilyl esters prior to chromatographic analysis. Lot 2 was also analysed quantitatively by gas-liquid chromatography; mannitol was added as an internal standard and peaks were identiEed by co-chromatography with authentic standards. Immunology. Strain 8021 was serogrouped by the slide agglutination technique, using hyperimmune rabbit antisera to the standard Walter Reed group Y and W135 strains (Evans et a/., 1968) .
Haemagglutinating antibody was assayed in the patient's acute and convalescent sera by a standard indirect haemagglutination assay (Artenstein et a/., 1971) .
The antigenic structure of strain 8021 capsular polysaccharide was analysed by double-diffusion in gel against hyperimmune serogrouping antisera using the Ouchterlony technique as described by Artenstein et a/. (1971), except that 0.9O/1, ion agar was employed. To ensure monospecificity of the antisera, each was absorbed with the standard strain of the opposite group (Gold & Wyle, 1970) .
R E S U L T S A N D D I S C U S S I O N
When initially reacted with the standard grouping antisera in the bacterial agglutination assay, strain 8021 gave a 4 + reaction with group W135 antiserum and a 2+ reaction with group Y antiserum. After storage for 1 month at 4 "C in the lyophilized state, strain 8021 gave 4 + agglutination reactions with both antisera. The progeny of ten single colony isolates from this passage (the fourth following initial isolation) all gave 4 + reactions with both antisera.
Analysis of the capsular polysaccharide extracted from strain 8021 revealed that it contained equimolar quantities of sialic acid and hexose (Table 1) . The hexose constituent consisted of 2-39 (lot I ) and 2.67 (lot 2) mol galactose for each mol glucose. Thus, the chemical constituents of both group-specific capsular polysaccharides were represented. Furthermore, the ratio of group W135 to group Y was consistent between the two lots, Fig. 1 . Analysis by double diffusion in agar of two lots of strain 8021 capsular polysaccharide reacted with absorbed antisera against groups Y and W135 capsular polysaccharides. The two gels (I and 11) differ only in the lot of 8021 polysaccharide used and in the distance between the wells. A, Group Y antiserum; B, group W135 antiserum; 1, group W135 capsular polysaccharide; 2, group Y capsular polysaccharide; 3, groups Y and W135 capsular polysaccharides; 4, strain 8021 capsular polysaccharide.
which were prepared from the progeny of two different single colony isolates, by slightly different techniques, in two different laboratories and several months apart.
Paired sera (acute and two-week convalescent) from the patient demonstrated a fourfold rise (1 : 16 to 1 : 64) in haemagglutinating antibody when reacted with erythrocytes sensitized with group W135 polysaccharide and an eightfold rise (I : 2 to I : 16) with group Y-sensitized erythrocytes.
To determine if the group W135 and group Y chemical constituents were present as separate molecular species or co-existed on a single molecule (mosaic), the capsular polysaccharide of strain 8021 was reacted with the absorbed group Y and group W 135 antisera by double diffusion in gel along with the two individual serogroup-specific polysaccharides and the bivalent combination. The two lots of 8021 capsular polysaccharide both contained individual molecules of each group-specific polysaccharide as well as a mosaic molecule, but the relative proportion of individual and mosaic molecules appeared to differ between the two preparations.
Representative gels, chosen for maximum demonstration of the separate molecular species (I) and the mosaic molecule (11) are presented in Fig. 1 . The gels differ only in the lot of 8021 capsular polysaccharide used and the distance between the wells. Since each antiserum contains capsular polysaccharide of the opposite serogroup, shed during absorption, a double precipitin line appears between them (wells A and B). The two lines may be distinguished by reference to the monovalent polysaccharides in wells 1 and 2. The bivalent vaccine, in well 3, clearly yields two lines of complete non-identity which symmetrically cross. In gel I, lot I of 8021 capsular polysaccharide (well 4) also yields two non-identical lines, whose crossing is asymmetrical. The group Y line is identical with that of the Y polysaccharide in the bivalent vaccine (well 3), while the group W 135 line is identical with that of the contaminating W135 polysaccharide in the group Y antiserum (well A) and the monovalent W 135 polysaccharide in well 1. In addition, a third very faint spur, not visible in the photograph, but represented in the sketch, was present between 8021 polysaccharide and Y antiserum, closer to the antiserum well.
In gel IT, where the wells are closer together and lot 2 of 8021 polysaccharide is in well 4, this spur can be seen more clearly. It is identical neither with the group Y polysaccharide in the bivalent vaccine (well 3), nor with the group Y contaminant in the W 135 antiserum.
Rather, it appears to be identical with the W135 component. We conclude, therefore, that although it represents the group Y antigenic component, it must migrate with the group W I35 component and represents a mosaic molecule consisting of both antigenic species.
Four possibilities exist to explain the production of both group Y and group W135 capsular polysaccharides by strain 8021 : (i) the isolate was a mixed culture containing strains of both serogroups; (ii) although a single strain was isolated, it elaborated both capsular polysaccharides as distinct molecular species ; (iii) both serogroup specific determinants were present on a single molecule (mosaic), or (iv) a combination of distinct molecular species and mosaic molecules was produced.
Although the patient's immunological response to both polysaccharides is consistent with co-infection with strains of each serogroup as well as co-production of each polysaccharide by a single strain, the first possibility seems remote. It would require that the patient was simultaneously infected by two different strains of N . rneningitidis, both of which simultaneously disseminated to the meninges and were isolated from cerebrospinal fluid. Furthermore, single colony progeny of the original isolate all reacted with both antisera and produced polysaccharides whose molar composition was similar.
The strongest argument against the presence of dual strains is the elaboration of a mosaic molecule. Although the two lots of 8021 polysaccharide appeared to differ in their proportion of single and mosaic molecules, the mosaic species was present in both. If strain 8021 elaborates the glycosylating enzymes to produce both a sialo-glucose and a sialo-galactose polymer, it could well produce both single and mosaic molecules, depending on cultural conditions. In this regard, the consistency of the galactose : glucose ratio between the two lots, which differed in their imrnunodiffusion patterns and in the amount of mosaic molecule they contained, is intriguing.
The results also raise intriguing genetic questions that await explanation. On a more practical level, strain 8021 may be useful for vaccine development, since both serogroup determinants could be prepared from a single seed strain, avoiding the increased reactogenicity inherent in combining polysaccharides from individual preparations (Farquhar et al., 1978) . Testing of a strain 8021 capsular polysaccharide vaccine in human volunteers is currently underway to determine its usefulness.
